Details for Patent: 8,987,262

✉ Email this page to a colleague

Which drugs does patent 8,987,262 protect, and when does it expire?

Patent 8,987,262 protects HEMANGEOL and is included in one NDA.

This patent has forty-seven patent family members in thirty-one countries.

Summary for Patent: 8,987,262

Patent landscape, scope, and claims:

Title:	Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
Abstract:	The present technology relates the use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas, for example of infantile hemangiomas. The beta blocker may be a non-selective beta-blocker, for example propranolol. The present technology provides an alternative to the known compounds, e.g. corticosteroids, interferon or vincristine, generally used for the treatment of hemangiomas.
Inventor(s):	Leaute-Labreze; Christine (Le Haillan, FR), Dumas De La Roque; Eric (Villenave d'Ornon, FR), Taieb; Alain (Bordeaux, FR), Thambo; Jean-Benoit (Bordeaux, FR)
Assignee:	Universite de Bordeaux (Bordeaux, FR) Centre Hospitalier Universitaire de Bordeaux (Talence, FR)
Application Number:	13/678,802
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,987,262
Patent Claim Types: see list of patent claims	Use; Formulation; Dosage form;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 8,987,262

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Pierre Fabre	HEMANGEOL	propranolol hydrochloride	SOLUTION;ORAL	205410-001	Mar 14, 2014		RX	Yes	Yes	⤷ Subscribe	⤷ Subscribe				METHOD TO TREAT INFANTILE HEMANGIOMA	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 8,987,262

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	07291273	Oct 19, 2007

International Family Members for US Patent 8,987,262

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	068927	⤷ Subscribe
Austria	E512661	⤷ Subscribe
Australia	2008313405	⤷ Subscribe
Brazil	PI0816536	⤷ Subscribe
Canada	2701953	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.